| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +0.00% | +13.98% | -0.44% | +14.42% | +14.42% | — |
| 14d | 3 | +100.00% | -0.22% | +0.87% | -1.09% | -1.09% | — |
| 30d | 3 | +0.00% | +50.20% | +1.36% | +48.84% | +48.84% | — |
| 60d | 3 | +0.00% | +25.00% | +5.84% | +19.16% | +19.16% | — |
| 90d | 3 | +0.00% | +22.93% | +7.18% | +15.75% | +15.75% | — |
| 180d | 3 | +0.00% | +62.60% | +14.90% | +47.70% | +47.70% | — |
| 1y | 3 | +0.00% | +135.25% | +25.73% | +109.53% | +109.53% | — |
| 2y | 3 | +100.00% | -32.39% | +6.49% | -38.88% | -38.88% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| NTLA INTELLIA THERAPEUTICS, INC. | SALE | 21,336 | $54.33 | $1.16M | 5,000 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | PURCHASE | 19,000 | $14.35 | $272.6K | 55,764 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | SALE | 19,000 | — | — | 0 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | SALE | 21,978 | $52.52 | $1.15M | 71,786 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | SALE | 31,764 | — | — | 0 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | SALE | 45,450 | $53.69 | $2.44M | 26,336 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | PURCHASE | 19,000 | $25.98 | $493.6K | 74,764 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | PURCHASE | 31,764 | $18.00 | $571.8K | 36,764 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | PURCHASE | 19,000 | $15.78 | $299.8K | 93,764 | Dec 17, 2020 | Dec 18, 2020 ↗ |
| NTLA INTELLIA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,000 | — | — | 19,000 | Jun 18, 2020 | Jun 19, 2020 ↗ |